Welmoed K van Deen
Overview
Explore the profile of Welmoed K van Deen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
479
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bosch D, van der Velden K, Belleman T, van Deen W, Bergman A, van der Doelen M, et al.
Clin Genitourin Cancer
. 2025 Mar;
:102317.
PMID: 40082112
Background: Androgen receptor targeted therapies (ART) play a major role in the treatment of metastatic castration-resistant prostate cancer (mCRPC). In recent years consensus has been reached that treatment with a...
2.
Wood D, Treiman K, Rivell A, van Deen W, Heyison H, Mattar M, et al.
Inflamm Bowel Dis
. 2024 Aug;
PMID: 39197162
Background: Previous research suggests patients living with inflammatory bowel disease (IBD) understand IBD remission differently than healthcare professionals, which could influence patient expectations and clinical outcomes. We investigated 3 questions...
3.
Dang N, Kumar S, Kwon M, Cradeur M, Zeven K, Khunte M, et al.
Inflamm Bowel Dis
. 2024 May;
31(2):593-596.
PMID: 38775837
No abstract available.
4.
Khalil C, van Deen W, Dupuy T, Syal G, Arnold C, Cazzetta S, et al.
Crohns Colitis 360
. 2023 Dec;
5(4):otad073.
PMID: 38046445
Background: Perianal fistulae can undermine physical, emotional, and social well-being in patients with Crohn's disease and are challenging to manage. Social media offers a rich opportunity to gain an in-depth...
5.
Long M, van Deen W, Weisbein L, Khalil C, Appel K, Zhang X, et al.
J Med Internet Res
. 2023 Aug;
25:e42921.
PMID: 37610821
Background: Patients with inflammatory bowel disease (IBD) are at increased risk of infections, bone fractures, and skin cancers. Objective: We developed preventive health videos using a patient-centered approach and tested...
6.
van Deen W, Freundlich N, Kwon M, Patel D, Crate D, Oberai R, et al.
Crohns Colitis 360
. 2023 Feb;
3(3):otab031.
PMID: 36776667
Background: Inflammatory bowel disease (IBD) care is beset with substantial practice variation. Learning health systems (LHSs) aim to learn from this variation and improve quality of care by sharing feedback...
7.
van Deen W, Khalil C, Bonthala N, Gale R, Patel D, Warui E, et al.
Dig Dis
. 2022 Dec;
41(3):412-421.
PMID: 36476714
Background: Multiple biologics are available to treat inflammatory bowel disease (IBD), which can either be administered subcutaneously or intravenously. The factors that determine patients' preferences for SC/IV administration in IBD...
8.
Kamp K, Hawes S, Tse C, Singh S, Dang N, Oberai R, et al.
Inflamm Bowel Dis
. 2022 Sep;
29(8):1255-1262.
PMID: 36179129
Background: Although validated patient-reported outcome (PRO) measurements can categorize patients with inflammatory bowel disease (IBD) into clinical remission or active disease, patients may have different definitions of remission. The purpose...
9.
Ho A, Kim S, Zalt C, Melany M, Chen I, Vasquez J, et al.
JAMA Oncol
. 2022 Sep;
PMID: 36107411
Importance: Unlike for prostate cancer, active surveillance for thyroid cancer has not achieved wide adoption. The parameters by which this approach is feasible are also not well defined, nor is...
10.
Scalia P, van Deen W, Engel J, Stevens G, Van Citters A, Holthoff M, et al.
Chronic Illn
. 2022 Aug;
18(3):708-716.
PMID: 35993673
There is increasing interest in asking patients questions before their visits to elicit goals and concerns, which is part of the move to support the concept of coproducing care. The...